Maltose Interference-Free Test Strips for Blood Glucose Testing at Point-of-Care: A Laboratory Performance Evaluation

被引:7
|
作者
Ng, Wai-Yoong [1 ]
Tiong, Chiau Chiae [1 ]
Jacob, Edward [1 ]
机构
[1] Singapore Gen Hosp, Dept Pathol, Singapore 169608, Singapore
关键词
ICODEXTRIN;
D O I
10.1089/dia.2010.0095
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Maltose interference is a concern with blood glucose testing at point-of-care. We evaluated a maltose interference-free test strip (with a modified recombinant glucose dehydrogenase-pyrroloquinoline quinone system) for the Accu-Chek (R) Performa glucose meter (Roche Diagnostics, Mannheim, Germany). Methods: Blood specimens (n - 120) sent for clinical laboratory glucose testing were used in assessing performance characteristics, including imprecision, linearity, clinical impact analysis, and method comparison, of the test strips. To evaluate sugar interference, two heparinized blood specimens were spiked with maltose, xylose, and galactose (up to 500 mg/dL) followed by testing with modified Performa, Accutrend (R) (Roche Diagnostics), and Advantage II (Roche Diagnostics) test strips and by the laboratory method. Results: Test strips demonstrated total laboratory coefficients of variation of <7%; within-run coefficients of variation were 2.7-5.4% for blood glucose at 2.5-19.7 mmol/L. Clarke Error Grid analysis of the 120 results (0.8-27.6 mmol/L) showed all values to be within critical clinical limits. Comparison with laboratory results gave 0.960 correlation (Spearman's r(2)) with a Deming regression y (Performa) 0.95x (laboratory) - 0.11 mmol/L (SEy vertical bar x0.06 mmol/L). A slight negative bias (-0.5 mmol/L) was demonstrated with the Bland-Altman difference plot. Maltose (up to 13.9 mmol/L) and xylose (33.3 mmol/L) had no effect, but galactose (2.2 mmol/L) showed interference. The sugars also affected test strips for Advantage II but not Accutrend glucose meters. With International Organization for Standardization ISO 15197:2003 criteria, 99% of the 120 results determined by the test strips were within the minimal acceptable performance; only one of 106 (5.9 mmol/L) was >20% from the laboratory result. Conclusions: The modified and improved Performa test strips were not affected by maltose and xylose. They meet ISO 15197:2003 requirements with a slight bias (-0.5 mmol/L) compared to the laboratory method.
引用
收藏
页码:889 / 893
页数:5
相关论文
共 50 条
  • [31] Use of Stabilized Whole Blood for Glucose Proficiency Testing at Point-of-Care Sites
    Liang, Shu-Ling
    Schmith, Eric
    Hunsley, Bradford
    Sornson, Hal
    Clarke, William
    POINT OF CARE, 2008, 7 (02): : 64 - 68
  • [32] A miniaturized photoacoustic device with laptop readout for point-of-care testing of blood glucose
    Zhang, Ya-Jie
    Chen, Shuai
    Yu, Yong-Liang
    Wang, Jian-Hua
    TALANTA, 2020, 209
  • [33] Performance evaluation of the epoc® point-of-care blood analysis system
    Chen, Yu
    Gorman, Monique
    O'Reilly, Bill
    CLINICAL BIOCHEMISTRY, 2015, 48 (15) : 1013 - 1013
  • [34] The variability of results between point-of-care testing glucose meters and the central laboratory analyzer
    Khan, Adil I.
    Vasquez, Yolanda
    Gray, Jacquelyn
    Wians, Frank H., Jr.
    Kroll, Martin H.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2006, 130 (10) : 1527 - 1532
  • [35] Evaluation of a Point-of-Care Testing Analyzer for Measuring Peripheral Blood Leukocytes
    Zhu, Huiqing
    Huang, Zhifeng
    Huang, Huimin
    Wang, Caiyou
    Wu, Liting
    Lin, Runpei
    Sun, Baoqing
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2022, (181):
  • [36] Frequencies and patterns of laboratory test requests from general practice: a service evaluation to inform point-of-care testing
    Fanshawe, Thomas R.
    Ordonez-Mena, Jose M.
    Turner, Philip J.
    Van den Bruel, Ann
    Shine, Brian
    Hayward, Gail N.
    JOURNAL OF CLINICAL PATHOLOGY, 2018, 71 (12) : 1065 - 1071
  • [37] Evaluation of a 10-second point-of-care test for betahydroxybutyrate in blood
    Ng, R.
    Winter, G.
    Bhogal, J.
    Phipps, L.
    Oxford, S.
    Patel, L.
    Ward, J.
    Harris, C.
    Pryor, H.
    Bennell, C.
    Bates, M.
    Scott, S.
    CLINICAL CHEMISTRY, 2007, 53 (06) : A217 - A217
  • [38] Performance of point-of-care glucose testing for the diagnosis of gestational diabetes in South Africa
    Khambule, L.
    Chikomba, C.
    Adam, Y.
    Khan, L.
    Haldane, C.
    Vetter, B.
    George, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2025, 168 (02) : 812 - 821
  • [39] Performance evaluation of the Precision™ PCx™ point-of-care blood glucose analyzer using discriminant ratio methodology
    Deyi, VYM
    Philippe, M
    Alexandre, KC
    Nayer, PD
    Hermans, MP
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2002, 40 (10) : 1052 - 1055
  • [40] Drug interference with glucose measurements on six handheld glucose meters and a portable glucose analyzer for point-of-care testing in critical care.
    Tang, ZP
    Du, XG
    Louie, RF
    Kost, GJ
    CLINICAL CHEMISTRY, 1999, 45 (06) : A31 - A32